Valerie Barlow, DVM, PhD, DACVP

Translational Science and Biomarker Development
Sanofi US

Dr. Valerie G. Barlow holds a DVM and Ph.D., and is a Diplomate of the American College of Veterinary Pathologists (clinical pathology). She is currently the Lead of the Translational Science and Biomarker Development group at Genzyme, a Sanofi Company, in Framingham, MA. Responsibilities in her current position include managing the biomarker assay development group, providing comprehensive translational support for projects, coordinating biomarker development processes for the Translational Medicine Unit, as well as providing clinical pathology support for the Disposition, Safety and Animal Research Scientific Core Platform. After obtaining her veterinary degree in Toulouse, France, Valerie went to Colorado State University where she completed a residency in Veterinary Clinical Pathology and obtained a Ph.D. in Pathology. She then joined Aventis, a Sanofi legacy company, as a Veterinary Clinical Pathologist in France. Valerie held a similar position when she moved back to the US and became the Head of the Biomarker/Clinical Pathology laboratory when relocated to Bridgewater, NJ. Most recently, she joined the newly formed Translational Medicine Unit at Genzyme. Throughout her career, Valerie has been involved with biomarkers, from preclinical safety biomarkers (her laboratory provided data for the ILSI consortium) to clinical biomarkers; from assay development to sample analysis under GLP conditions. She is one of the Sanofi representatives for C-Path and the FNIH Biomarker Consortium. Prior to her move to Massachusetts, Valerie was an Adjunct Professor the University of Pennsylvania School of Veterinary Medicine. She likes to spend her free time with family, running after her rambunctious 5-year-old boy, riding her Harley with her husband, and trying new recipes with friends.